Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Cited by (1,000)

Items 201–300 of 1,000

1. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19
   Qingqin Tan, Lingjie He, Xiaojun Meng, Wei Wang, Hudan Pan, Weiguo Yin, Tianchuan Zhu, Xi Huang, Hong Shan · 2021 · Journal of Nanobiotechnology
2. Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series
   Andrew G. Weber, Alice S. Chau, Mikala Egeblad, Betsy Jo Barnes, Tobias Janowitz · 2020 · Molecular Medicine
3. The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness
   Craig M. Coopersmith, Massimo M. Antonelli, Seth R. Bauer, Clifford Scott Deutschman, Laura Evans, Ricard Ferrer, Judith Hellman, Sameer Jog, Jozef Kesecioğlu, Niranjan “Tex” Kissoon et al. · 2021 · Critical Care Medicine
4. The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients
   Zainab Thanon Hasan, Mohammed Qasim Yahya Malallah A. Al-Atrakji, Ahmed Kayes Mehuaiden · 2021 · International Journal of Infectious Diseases
5. Bioinspired DNase‐I‐Coated Melanin‐Like Nanospheres for Modulation of Infection‐Associated NETosis Dysregulation
   Hee Ho Park, Wooram Park, Yun Young Lee, Hyelim Kim, Hee Seung Seo, Dong Wook Choi, Ho‐Keun Kwon, Dong Hee Na, Taehyung P. Kim, Young Bin Choy et al. · 2020 · Advanced Science
6. Elastase and exacerbation of neutrophil innate immunity are involved in multi‐visceral manifestations of COVID‐19
   Jean‐Louis Guéant, Rosa‐Maria Guéant‐Rodriguez, Julien Fromonot, Abderrahim Oussalah, Huguette Louis, Céline Chéry, Mickael Gette, Stanislas Gleye, Jonas Callet, Jérémie Raso et al. · 2021 · Allergy
7. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19
   Aiping Ma, Liang Zhang, Xiaokai Ye, Jing Chen, Jie Yu, Liangjin Zhuang, Chaohang Weng, Frank Petersen, Zhanxiang Wang, Xinhua Yu · 2021 · Frontiers in Immunology
8. Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19
   Qiong Zhang, Yuting Meng, Kaihang Wang, Xujun Zhang, Wenbiao Chen, Jifang Sheng, Yunqing Qiu, Hongyan Diao, Lanjuan Li · 2021 · Frontiers in Immunology
9. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
   Magda Lourda, Majda Dzidic, Laura Hertwig, Helena Bergsten, Laura Marcela Palma Medina, Indranil Sinha, Egle Kvedaraite, Puran Chen, Jagadeeswara Rao Muvva, Jean‐Baptiste Gorin et al. · 2021 · Proceedings of the National Academy of Sciences
10. Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy
    Xia Li, Mi Shao, Xiangjun Zeng, Pengxu Qian, He Huang · 2021 · Signal Transduction and Targeted Therapy
11. Traditional herbs against COVID-19: back to old weapons to combat the new pandemic
    Hayder Mutter Al-Kuraishy, Omnia Momtaz Al-Fakhrany, Engy Elekhnawy, Ali Ismail Al-Gareeb, Mohammed Alorabi, Michel MDW DE WAARD, Sarah M. Albogami, Gaber El‐Saber Batiha · 2022 · European journal of medical research
12. COVID-19 vaccines adverse events: potential molecular mechanisms
    Malamatenia Lamprinou, Athanasios Sachinidis, Εleni Stamoula, Theofanis Vavilis, Georgios Papazisis · 2023 · Immunologic Research
13. Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19
    Fahim Syed, Wei Li, Ryan F. Relich, Patrick M. Russell, Shanxiang Zhang, Michelle K. Zimmerman, Qigui Yu · 2021 · The Journal of Infectious Diseases
14. The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction
    Helena Block, Jan Rossaint, Alexander Zarbock · 2022 · Cells
15. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
    Nichola Cooper, Waleed Ghanima, Quentin A. Hill, Phillip L.R. Nicolson, Vadim V. Markovtsov, Craig M. Kessler · 2022 · Platelets
16. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop
    Ahmed Yaqinuddin, Junaid Kashir · 2020 · Medical Hypotheses
17. Neurological consequences of COVID-19: what have we learned and where do we go from here?
    Abbas Jarrahi, Meenakshi Ahluwalia, Hesam Khodadadi, Évila Lopes Salles, Ravindra B Kolhe, David Charles Hess, Fernando Ĺ. Vale, Manish Kumar, Babak Baban, Kumar Vaibhav et al. · 2020 · Journal of Neuroinflammation
18. Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies
    Cornelius Joseph Clancy, Ilan Steven Schwartz, Brittany Kula, M. Hong Nguyen · 2021 · Open Forum Infectious Diseases
19. Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm
    Jyoti Kanwar Shekhawat, Kavya Gauba, Shruti Gupta, Purvi Purohit, Prasenjit Mitra, Mahendra Kumar Garg, Sanjeev Misra, Praveen Sharma, Mithu Banerjee · 2021 · Indian Journal of Clinical Biochemistry
20. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis
    Mehdi Sakka, Jean M. Connors, Guillaume Hékimian, Isabelle Martin‐Toutain, Benjamin Crichi, Inés Colmegna, Dominique Bonnefont‐Rousselot, Dominique Farge, Corinne Frère · 2020 · JMV-Journal de Médecine Vasculaire
21. Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still’s disease pathogenesis
    Jinchao Jia, Mengyan Wang, Jianfen Meng, Yuning Ma, Yang Wang, Naijun Miao, Jialin Teng, Dehao Zhu, Hui Shi, Yue Sun et al. · 2022 · Nature Communications
22. Coagulation Dysfunction
    Yang Fei, Ning Tang, Hefei Liu, Wenjing Cao · 2020 · Archives of Pathology & Laboratory Medicine
23. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
    Vincent J. Venditto, Dalia Haydar, Ahmed Abdel‐Latif, John C. Gensel, Michael Anstead, Michelle G. Pitts, Jarrod W. Creameans, Timothy Joseph Kopper, Chi Peng, David J. Feola · 2021 · Frontiers in Immunology
24. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
    Praveen Mathews Varghese, Anthony George Tsolaki, Hadida Yasmin, Abhishek Shastri, Janez Ferluga, Manu Vatish, Taruna Madan, Uday Kishore · 2020 · Immunobiology
25. The Role of Cytokines in Neutrophil Development, Tissue Homing, Function and Plasticity in Health and Disease
    Maria Tsioumpekou, Daniëlle Krijgsman, Jeanette H.W. Leusen, Patricia A. Olofsen · 2023 · Cells
26. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
    Sarah Halawa, Soni Savai Pullamsetti, Charles R. M. Bangham, Kurt R. Stenmark, Peter Dorfmüller, Maria G. Frid, GHAZWAN S. BUTROUS, Nicholas W. Morrell, Vinicio de Jesús Pérez, David Ian Stuart et al. · 2021 · Nature Reviews Cardiology
27. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
    Hayder Mutter Al-Kuraishy, Gaber El‐Saber Batiha, Hani Saleh Faidah, Ali Ismail Al-Gareeb, ‏Hebatallah M. Saad, Jesús Simal‐Gándara · 2022 · Inflammopharmacology
28. Novel neutrophil extracellular trap-related mechanisms in diabetic wounds inspire a promising treatment strategy with hypoxia-challenged small extracellular vesicles
    Ziqiang Chu, Qilin Huang, Kui Ma, Xi Liu, Wen‐Hua Zhang, Shengnan Cui, Qian Wei, Huanhuan Gao, Wenzhi Hu, Zihao Wang et al. · 2023 · Bioactive Materials
29. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts
    Liuliu Yang, Yuling Han, Fabrice Jaffré, Benjamin E. Nilsson-Payant, Yaron Bram, Pengfei Wang, Jiajun Zhu, Tuo Zhang, David Redmond, Sean Houghton et al. · 2021 · Circulation Research
30. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
    J. Hazeldine, J. Lord · 2021 · Frontiers in Immunology
31. Characterization of low-density granulocytes in COVID-19
    Luz E. Cabrera, Pirkka T. Pekkarinen, Maria Alander, Kirsten Nowlan, Ngoc-anh A. Nguyen, Suvi Tuulia Jokiranta, Suvi H. Kuivanen, Anu Patjas, Sointu Mero, Sari H. Pakkanen et al. · 2021 · PLoS Pathogens
32. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
    Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lü, Ming Wang, Lin Zhu et al. · 2022 · Signal Transduction and Targeted Therapy
33. Repurposing anticancer drugs for the management of COVID-19
    Khalid El Bairi, Dario Trapani, Angelica Petrillo, Cécile Le Page, Hanaâ Zbakh, Bruno Daniele, Rhizlane Belbaraka, Giuseppe Curigliano, Saïd Afqir · 2020 · European Journal of Cancer
34. Mechanistic investigations of diabetic ocular surface diseases
    Qingjun Zhou, Lingling Yang, Qun Wang, Ya Li, Chao Wei, Lixin Xie · 2022 · Frontiers in Endocrinology
35. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
    Corleone S. Delaveris, Aaron J. Wilk, Nicholas McIlvain Riley, Jessica C. Stark, Samuel S. Yang, Angela J. Rogers, Thanmayi Ranganath, Kari Christine Nadeau, The Stanford COVID-19 Biobank, Catherine A. Blish et al. · 2021 · ACS Central Science
36. High generation of reactive oxygen species from neutrophils in patients with severe COVID-19
    Tonny Veenith, Helena M. Martin, Martin Le Breuilly, Tony Whitehouse, Fang Gao Smith, Niharika Arora Duggal, Janet M. Lord, Rubina Mian, David Sarphie, Paul A. H. Moss · 2022 · Scientific Reports
37. Bibliometric and visual analysis of neutrophil extracellular traps from 2004 to 2022
    Yantong Wan, Junyi Shen, Jiafu Ouyang, Peng Dong, Yinghao Hong, Lixin Liang, Jinghua Liu · 2022 · Frontiers in Immunology
38. Blood clots in COVID-19 patients: Simplifying the curious mystery
    Biswas, Sourav, Thakur, Vikram, Kaur, Parneet, Khan, Azhar, Kulshrestha, Saurabh, Kumar, Pradeep · 2021 · Medical Hypotheses
39. Tissue Factor-Enriched Neutrophil Extracellular Traps Promote Immunothrombosis and Disease Progression in Sepsis-Induced Lung Injury
    Hao Zhang, Yilu Zhou, Mengdi Qu, Ying Yu, Zhaoyuan Chen, Shuainan Zhu, Kefang Guo, Wankun Chen, Changhong Miao · 2021 · Frontiers in Cellular and Infection Microbiology
40. Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID‐19‐associated thrombopathy
    Antoine Caillon, Antonin Trimaille, Julie Favre, Laurence Jesel, Olivier Morel, Gilles Kauffenstein · 2021 · Journal of Thrombosis and Haemostasis
41. Neutrophil heterogeneity and fate in inflamed tissues: implications for the resolution of inflammation
    János G. Filep, Amiram Ariel · 2020 · American Journal of Physiology-Cell Physiology
42. Severe COVID-19: what have we learned with the immunopathogenesis?
    Bruno Bordallo Corrêa, Mozart Bellas Rodrigues, Arthur Fernandes Cortez, Matheus Vieira, Marcelo M. Pinheiro · 2020 · Revista Brasileira de Reumatologia
43. Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α
    Paolo Frisoni, Margherita Neri, Stefano D’Errico, Letizia Alfieri, Diana Bonuccelli, Mariano Cingolani, Marco Di Paolo, Rosa Maria Gaudio, Maurizio Lestani, Matteo Marti et al. · 2021 · Forensic Science Medicine and Pathology
44. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury
    Xianyang Chen, Huifang Guo, Qiu Li, Chengdong Zhang, Qiang Deng, Qibin Leng · 2020 · Frontiers in Immunology
45. Pathophysiological mechanisms of thrombosis in acute and long COVID-19
    Haijiao Jing, Xiaoming Wu, Mengqi Xiang, Langjiao Liu, Valerie Anne Novakovic, Jialan Shi · 2022 · Frontiers in Immunology
46. Proteome Profiling of Recombinant DNase Therapy in Reducing NETs and Aiding Recovery in COVID-19 Patients
    Jane Fisher, Tirthankar Mohanty, Christofer A. Q. Karlsson, S. M. Hossein Khademi, Erik Malmström, Attila Frigyesi, Pontus Nordenfelt, Johan A. Malmström, Adam Linder · 2021 · Molecular & Cellular Proteomics
47. An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment
    Andréa D. Fuzimoto · 2021 · Journal of Chinese Integrative Medicine
48. Neutrophil autophagy and NETosis in COVID-19: perspectives
    Ruoyu Zhang, Chen Sun, Yunze Han, Leo Huang, Honghui Sheng, Jing Wang, Yuqing Zhang, Jonathan Lai, Jiahao Yuan, Xuemei Chen et al. · 2022 · Autophagy
49. Neutrophils in COVID-19: recent insights and advances
    Jiayu Li, Kegong Zhang, Ye Zhang, Ziyang Gu, Chang–Xing Huang · 2023 · Virology Journal
50. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
    Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, Chiara Romei, Claudia Martini · 2021 · Biochemical Pharmacology
51. Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
    Brice Korkmaz, Adam Lesner, Sylvain Marchand-Adam, Celia Moss, Dieter E. Jenne · 2020 · Journal of Medicinal Chemistry
52. Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle
    Tima Dehghani, Alyssa Panitch · 2020 · Open Biology
53. TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
    Gillina F. G. Bezemer, Johan Garssen · 2021 · Frontiers in Pharmacology
54. Neutrophil Extracellular Traps in Cancer Therapy Resistance
    Muhammad H. Shahzad, Lixuan Feng, Xin Su, Ariane Brassard, Iqraa Dhoparee‐Doomah, Lorenzo Edwin Ferri, Jonathan David Spicer, Jonathan Cools‐Lartigue · 2022 · Cancers
55. Chitin and chitosan as tools to combat COVID-19: A triple approach
    Mehrnoush Safarzadeh, Sahar Sadeghi, Mahdieh Azizi, Mohsen Rastegari‐Pouyani, Ramin Pouriran, Mostafa Haji Molla Hoseini · 2021 · International Journal of Biological Macromolecules
56. Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C
    Yanfang Peipei Zhu, Isaac Shamie, Jamie Casey Lee, Cameron J. Nowell, Weiqi Peng, Shiela Angulo, Linh Le, Yushan Liu, Huilai Miao, Hainan Xiong et al. · 2021 · Journal of Clinical Investigation
57. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
    Inés Valencia, Jairo Lumpuy‐Castillo, Giselle Santos Magalhães, Carlos F. Sánchez‐Ferrer, Óscar Lorenzo, Concepción Peiró · 2024 · Cardiovascular Diabetology
58. Perspective: The Potential Effects of Naringenin in COVID-19
    Ricardo Wesley Alberca, Franciane Mouradian Emidio Teixeira, Danielle Rosa Beserra, Emily Araujo de Oliveira, Milena Mary de Souza Andrade, Anna Julia Pietrobon, Maria Notomi Sato · 2020 · Frontiers in Immunology
59. SARS‐COV‐2–associated coagulopathy and thromboembolism prophylaxis in children: A single‐center observational study
    Giovanni Del Borrello, Isaac Giraudo, Claudia Bondone, Marco Denina, Silvia Garazzino, Claudia Linari, Federica Mignone, Giulia Pruccoli, Carlo Scolfaro, Manuela Spadea et al. · 2020 · Journal of Thrombosis and Haemostasis
60. A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation
    Yuanfang Chen, Liu Ouyang, Forrest Sheng Bao, Qian Li, Lei Han, Hengdong Zhang, Baoli Zhu, Yaorong Ge, Patrick A. Robinson, Ming Jing Xu et al. · 2021 · Journal of Medical Internet Research
61. The pathogenesis of coronavirus-19 disease
    Alain Borczuk, Rhonda K. Yantiss · 2022 · Journal of Biomedical Science
62. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model
    Kaspi, Haggai, Semo, Jonathan, Abramov, Nathalie, Dekel, Chen, Lindborg, Stacy, Kern, Ralph, Lebovits, Chaim, Aricha, Revital · 2021 · Stem Cell Research & Therapy
63. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry
    Chuan Xu, Annie Wang, M. Marin, W. Honnen, Santhamani Ramasamy, E. Porter, S. Subbian, A. Pinter, G. Melikyan, Wu-Yuan Lu et al. · 2021 · Viruses
64. IgA potentiates NETosis in response to viral infection
    Hannah D. Stacey, Diana Golubeva, Alyssa Posca, Jann Catherine Ang, Kyle E. Novakowski, Muhammad Atif Zahoor, Charu Kaushic, Ewa Cairns, Dawn M. E. Bowdish, Caitlin E. Mullarkey et al. · 2021 · Proceedings of the National Academy of Sciences
65. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
    Zhangjing Ma, Yi Yang, Yü Huang, Kathy O. Lui · 2021 · Journal of Molecular and Cellular Cardiology
66. Mesenchymal stem cell-derived extracellular vesicles accelerate diabetic wound healing by inhibiting NET-induced ferroptosis of endothelial cells
    Wei Lü, Xiaoyang Li, Zheyu Wang, Changbo Zhao, Qi Li, Lei Zhang, Shuofei Yang · 2024 · International Journal of Biological Sciences
67. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
    Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino · 2020 · Annals of Hematology
68. COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications
    Michael Peter Schön, Carola Berking, Tilo Biedermann, Timo Buhl, Luise Erpenbeck, Kilian Eyerich, Stefanie Eyerich, Kamran Ghoreschi, Matthias Goebeler, Ralf Joachim Ludwig et al. · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
69. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019
    Werner J. D. Ouwendijk, Matthijs P. Raadsen, Jeroen J. A. van Kampen, Robert M. Verdijk, Jan H. von der Thüsen, Lihui Guo, Rogier A.S. Hoek, Johannes P. C. van den Akker, Henrik Endeman, Thomas Langerak et al. · 2021 · The Journal of Infectious Diseases
70. Regulatory mechanisms of neutrophil migration from the circulation to the airspace
    Wan-Chi Lin, Michael B. Fessler · 2021 · Cellular and Molecular Life Sciences
71. Recent Advances on Nanomaterials to COVID‐19 Management: A Systematic Review on Antiviral/Virucidal Agents and Mechanisms of SARS‐CoV‐2 Inhibition/Inactivation
    Anna Paula Azevedo de Carvalho, Carlos Adam Conte‐Júnior · 2021 · Global Challenges
72. Binding of colchicine and ascorbic acid (vitamin C) to bovine serum albumin: An in-vitro interaction study using multispectroscopic, molecular docking and molecular dynamics simulation study
    Tanveer Ahmad Wani, Nawaf A. Alsaif, Mohammed Mater Alanazi, Ahmed H.H. Bakheit, Azmat Ali Khan, Seema Zargar · 2021 · Journal of Molecular Liquids
73. Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19
    Zachary M. Holliday, Alexander Earhart, Mohammed M. Alnijoumi, Armin Krvavac, Lee‐Ann H. Allen, Adam G. Schrum · 2021 · Frontiers in Immunology
74. Iron and iron-related proteins in COVID-19
    Erin Suriawinata, Kosha J. Mehta · 2022 · Clinical and Experimental Medicine
75. High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
    Xiaosheng Liu, Wei Cao, Taisheng Li · 2020 · Frontiers in Immunology
76. Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
    Flavio Protasio Veras, Giovanni Freitas Gomes, Bruna M. S. Silva, Diego B. Caetité, Cicero J. L. R. Almeida, Camila Meirelles Souza Silva, Ayda Henriques Schneider, Emily da Silva Córneo, Caio Santos Bonilha, Sabrina Setembre Batah et al. · 2023 · Respiratory Research
77. SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy
    Shuxin Liang, Changlei Bao, Zi F. Yang, Shiyun Liu, Yanan Sun, Weitao Cao, Ting Wang, Tae-Hwi Linus Schwantes-An, John S. Choy, Samisubbu R. Naidu et al. · 2023 · Signal Transduction and Targeted Therapy
78. Could Ergothioneine Aid in the Treatment of Coronavirus Patients?
    Irwin Kee-Mun Cheah, Barry B. Halliwell · 2020 · Antioxidants
79. SARS-CoV-2 and cancer: Are they really partners in crime?
    Peter A. van Dam, Manon Thirza Huizing, Gino Mestach, Stazie Dierckxsens, Wiebren A.A. Tjalma, Xuan Bich Trinh, Kostantinos Papadimitriou, Sevilay Altıntaş, Jan Baptist Vermorken, Christof Vulsteke et al. · 2020 · Cancer Treatment Reviews
80. The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression
    Wei Chieh Huang, Mei Li, Guangwei Luo, Xiaojie Wu, Bintao Su, Lan Zhao, Shuang Zhang, Xiaofan Chen, Min Jia, Jianhua Zhu et al. · 2021 · The Journal of Immunology
81. Persistence of neutrophil extracellular traps and anticardiolipin auto‐antibodies in post‐acute phase COVID‐19 patients
    Ekaterina Pisareva, Stéphanie Badiou, Lucia Mihalovičová, Alexia Mirandola, Brice Pastor, Andrei Kudriavtsev, Marie Berger, C. Roubille, Pierre Fesler, Kada Klouche et al. · 2022 · Journal of Medical Virology
82. Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
    Ligong Lu, Hui Zhang, Meixiao Zhan, Jun Jiang, Hua Yin, Danielle J. Dauphars, Shi-You Li, Yong Li, You-Wen He · 2020 · Frontiers in Cell and Developmental Biology
83. Recombinant human DNase-I improves acute respiratory distress syndrome via neutrophil extracellular trap degradation
    Abbas Jarrahi, Hesam Khodadadi, Nicholas Moore, Yujiao Lu, Mohamed E. Awad, Évila Lopes Salles, Kumar Vaibhav, Babak Baban, Krishnan M. Dhandapani · 2023 · Journal of Thrombosis and Haemostasis
84. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System
    Matthew A. Sparks, Andrew Michael South, Andrew D. Badley, Carissa Marrie Baker-Smith, DANIEL C. BATLLE, Biykem Bozkurt, Roberto Cattaneo, Steven D. Crowley, Louis J. Dell’Italia, Andria L. Ford et al. · 2020 · Hypertension
85. Systematic Review of Microthrombi in COVID-19 Autopsies
    Rafael Santiago Parra-Medina, Sabrina Herrera, Jaime Piracoca Mejìa · 2021 · Acta Haematologica
86. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
    Alexander Earhart, Zachary M. Holliday, H.V. Hofmann, Adam G. Schrum · 2020 · New Microbes and New Infections
87. On Neutrophil Extracellular Trap (NET) Removal: What We Know Thus Far and Why So Little
    Michał Santocki, Elżbieta Kołaczkowska · 2020 · Cells
88. COVID‐19 and immunothrombosis: emerging understanding and clinical management
    Rebecca Shaw, Charlotte Ann Bradbury, Simon Timothy Abrams, Guozheng Wang, Cheng‐Hock Toh · 2021 · British Journal of Haematology
89. Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives.
    Shinde, Tanvi, Hansbro, Philip M, Sohal, Sukhwinder Singh, Dingle, Peter, Eri, Rajaraman, Stanley, Roger · 2020 · Microorganisms
90. COVID-19 and ethnicity: A novel pathophysiological role for inflammation
    Abhinav Vepa, Joseph P. Bae, Faheem Ahmed, Manish Pareek, Kamlesh K. Khunti · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
91. NETosis as a Pathogenic Factor for Heart Failure
    Shuang Ling, Jin‐Wen Xu · 2021 · Oxidative Medicine and Cellular Longevity
92. A Narrative Review: The Role of NETs in Acute Respiratory Distress Syndrome/Acute Lung Injury
    Xinyu Zhou, Jiajia Jin, Tangfeng Lv, Yong Song · 2024 · International Journal of Molecular Sciences
93. Pulmonary pathology of COVID-19: a review of autopsy studies
    Alain Borczuk · 2021 · Current Opinion in Pulmonary Medicine
94. COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases
    Silvana Valdebenito, Simon Bessis, Djillali Annane, Geoffroy Lorin de la Grandmaison, Elisabeth Martin Cramer, Brendan Prideaux, Eliseo A. Eugenín, Morgane Bomsel · 2021 · Frontiers in Immunology
95. ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review
    Arun Prabhahar, GSRSNK Naidu, Prabhat Chauhan, Aravind Sekar, Aman Sharma, Alok Kumar Sharma, Asheesh Kumar, Ritambhra Nada, Manish Rathi, Harbir Singh Kohli et al. · 2022 · Rheumatology International
96. Targeting NETs using dual-active DNase1 variants
    Hanna Englert, Josephine Göbel, Danika Khong, Maryam Omidi, Nina Wolska, Sandra Konrath, Maike Frye, Reiner K. Mailer, Manu Beerens, Julian C. Gerwers et al. · 2023 · Frontiers in Immunology
97. IL-17: Balancing Protective Immunity and Pathogenesis
    Lu Sun, Lufei Wang, Bethany B. Moore, Shaoping Zhang, Peng Xiao, Ann M. Decker, Hom‐Lay Wang · 2023 · Journal of Immunology Research
98. Beyond host defense and tissue injury: the emerging role of neutrophils in tissue repair
    Salma A. Rizo-Téllez, János G. Filep · 2024 · American Journal of Physiology-Cell Physiology
99. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19
    Xiyuan Bai, Joseph A. Hippensteel, Alida Leavitt, James P. Maloney, John David Beckham, Cindy Garcia, Qing Li, Brian M. Freed, Diane J. Ordway, Robert A. Sandhaus et al. · 2020 · Medical Hypotheses
100. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection
     Andrea T. Obi, Geoffrey D. Barnes, Lena M. Napolitano, Peter K. Henke, Thomas W. Wakefield · 2020 · Journal of Vascular Surgery Venous and Lymphatic Disorders